Universe Pharmaceuticals Operating Expenses Growth & History (UPC)
Universe Pharmaceuticals's operating expenses was $9.22B for fiscal 2025.
View full Universe Pharmaceuticals company overviewUniverse Pharmaceuticals annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | $9.22B | −$4.87B | −34.59% |
| 2024 | 2024-09-30 | $14.09B | $14.08B | +98573.13% |
| 2023 | 2023-09-30 | $14.3M | −$14.6M | −50.60% |
| 2022 | 2022-09-30 | $28.9M | $17.2M | +146.34% |
| 2021 | 2021-09-30 | $11.7M | $7.9M | +205.46% |
| 2020 | 2020-09-30 | $3.8M | $187,439 | +5.13% |
| 2019 | 2019-09-30 | $3.7M | — | — |
Universe Pharmaceuticals operating expenses trends
Over the last five fiscal years, Universe Pharmaceuticals's operating expenses increased from $3.8M to $9.22B, a change of $9.21B.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Universe Pharmaceuticals source filings ↗